Adsorption of bisphosphonate onto hydrox
β
Kate McLeod; Gail I. Anderson; Naba K. Dutta; Roger St.C. Smart; Nicolas H. Voel
π
Article
π
2006
π
John Wiley and Sons
π
English
β 496 KB
## Abstract Premature bone resorption and remodeling by osteoclasts can limit the longevity of implant fixation and recovery time. Orally administered bisphosphonates (BPs) have been used to inhibit osteoclast action at the implant/bone interface. Ideally, these should be delivered at the interface